{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [], "SpaceFlightMission": [], "InvestigatorList": [], "OtherAbstract": [], "OtherID": [], "CitationSubset": ["IM"], "GeneralNote": [], "PMID": "29850450", "DateCompleted": {"Year": "2019", "Month": "04", "Day": "03"}, "DateRevised": {"Year": "2019", "Month": "04", "Day": "03"}, "Article": {"ArticleDate": [{"Year": "2018", "Month": "04", "Day": "17"}], "Language": ["eng"], "ELocationID": ["1053710", "10.1155/2018/1053710"], "Journal": {"ISSN": "2291-2797", "JournalIssue": {"Volume": "2018", "PubDate": {"Year": "2018"}}, "Title": "Canadian journal of gastroenterology & hepatology", "ISOAbbreviation": "Can J Gastroenterol Hepatol"}, "ArticleTitle": "The Effects of Extra Virgin Olive Oil on Alanine Aminotransferase, Aspartate Aminotransferase, and Ultrasonographic Indices of Hepatic Steatosis in Nonalcoholic Fatty Liver Disease Patients Undergoing Low Calorie Diet.", "Pagination": {"StartPage": "1053710", "MedlinePgn": "1053710"}, "Abstract": {"AbstractText": ["Coronary artery disease is the most common cause of death in the patients with nonalcoholic fatty liver disease (NAFLD). Studies have shown that there is a strong relation between the increase in the aminotransferase levels and fat accumulation in the liver with cardiovascular complications, independent of all aspects of the metabolic syndrome. This study aimed to examine the effect of virgin olive oil on alanine aminotransferase (ALT) and aspartate aminotransferase (AST) and the severity of steatosis in the NAFLD patients undergoing a weight-loss diet.", "This clinical trial was carried out on 50 patients with nonalcoholic fatty liver (mean age of 45.91 \u00b1 9.61 years, mean BMI of 29.7 \u00b1 0.58\u2009Kg/m<sup>2</sup>) and the subjects were randomly assigned to the olive oil group (receiving the equivalent of 20% of their total daily energy requirement from olive oil) or the control group (with normal consumption of oil) for 12 weeks. All the patients received a hypocaloric diet during the study. At the beginning and the end of the study, the serum levels of ALT and AST and liver steatosis were measured.", "A significant decrease in the level of ALT enzymes was observed in the control group at the end of the study (<i>P</i> = 0.004). In the olive oil group, both enzymes decreased compared to baseline measurements (<i>P</i> < 0.01). There were significant differences in the ALT and AST levels between the two groups (<i>P</i> < 0.02). The severity of liver steatosis did not change significantly during the study.", "The consumption of a low calorie diet enriched with olive oil, along with slight weight reduction, reinforces the desired effects of weight loss in improving the levels of the hepatic enzymes."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Nutrition, School of Public Health, Iran University of Medical Sciences, Tehran, Iran."}], "LastName": "Shidfar", "ForeName": "Farzad", "Initials": "F"}, {"Identifier": ["0000-0002-4528-9499"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Nutrition, School of Public Health, Iran University of Medical Sciences, Tehran, Iran."}], "LastName": "Bahrololumi", "ForeName": "Samaneh Sadat", "Initials": "SS"}, {"Identifier": ["0000-0002-2532-7478"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Natural Products and Medicinal Plants Research Center, North Khorasan University of Medical Sciences, Bojnurd, Iran."}, {"Identifier": [], "Affiliation": "Department of Public Health, School of Health, North Khorasan University of Medical Sciences, Bojnurd, Iran."}], "LastName": "Doaei", "ForeName": "Saeid", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Nutrition Sciences, Student Research Committee, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran."}], "LastName": "Mohammadzadeh", "ForeName": "Assieh", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Student Research Committee, Cancer Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran."}], "LastName": "Gholamalizadeh", "ForeName": "Maryam", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Student Counseling Center, Hamadan University of Medical Sciences, Hamadan, Iran."}], "LastName": "Mohammadimanesh", "ForeName": "Ali", "Initials": "A"}], "PublicationTypeList": ["Journal Article", "Randomized Controlled Trial"]}, "MedlineJournalInfo": {"Country": "Egypt", "MedlineTA": "Can J Gastroenterol Hepatol", "NlmUniqueID": "101623613", "ISSNLinking": "2291-2789"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Biomarkers"}, {"RegistryNumber": "0", "NameOfSubstance": "Olive Oil"}, {"RegistryNumber": "EC 2.6.1.1", "NameOfSubstance": "Aspartate Aminotransferases"}, {"RegistryNumber": "EC 2.6.1.2", "NameOfSubstance": "Alanine Transaminase"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Adult"}, {"QualifierName": [], "DescriptorName": "Aged"}, {"QualifierName": ["blood"], "DescriptorName": "Alanine Transaminase"}, {"QualifierName": ["blood"], "DescriptorName": "Aspartate Aminotransferases"}, {"QualifierName": ["blood"], "DescriptorName": "Biomarkers"}, {"QualifierName": ["methods"], "DescriptorName": "Caloric Restriction"}, {"QualifierName": ["methods"], "DescriptorName": "Diet, Reducing"}, {"QualifierName": ["blood", "diagnosis", "diet therapy"], "DescriptorName": "Fatty Liver"}, {"QualifierName": [], "DescriptorName": "Female"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["diagnostic imaging"], "DescriptorName": "Liver"}, {"QualifierName": [], "DescriptorName": "Male"}, {"QualifierName": [], "DescriptorName": "Middle Aged"}, {"QualifierName": ["blood", "diagnosis", "diet therapy"], "DescriptorName": "Non-alcoholic Fatty Liver Disease"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Olive Oil"}, {"QualifierName": [], "DescriptorName": "Single-Blind Method"}, {"QualifierName": [], "DescriptorName": "Treatment Outcome"}, {"QualifierName": [], "DescriptorName": "Ultrasonography"}, {"QualifierName": [], "DescriptorName": "Young Adult"}]}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Byrne C. D., Olufad R., Bruce K. D., Cagampang F. R., Ahmed M. H. Metabolic disturbances in non-alcoholic fatty liver disease. Clinical Science. 2009;116(7):539\u2013564. doi: 10.1042/CS20080253.", "ArticleIdList": ["10.1042/CS20080253", "19243311"]}, {"Citation": "Obika M., Noguchi H. Diagnosis and evaluation of nonalcoholic fatty liver disease. Journal of Diabetes Research. 2012;2012:12. doi: 10.1155/2012/145754.145754", "ArticleIdList": ["10.1155/2012/145754", "PMC3205741", "22110476"]}, {"Citation": "Baharvand-Ahmadi B., Sharifi K., Namdari M. Prevalence of non-alcoholic fatty liver disease in patients with coronary artery disease. ARYA Atherosclerosis. 2016;12(4):201\u2013205.", "ArticleIdList": ["PMC5266138", "28149317"]}, {"Citation": "Motamed N., Rabiee B., Poustchi H., et al. Non-alcoholic fatty liver disease (NAFLD) and 10-year risk of cardiovascular diseases. Clinics and Research in Hepatology and Gastroenterology. 2017;41(1):31\u201338. doi: 10.1016/j.clinre.2016.07.005.", "ArticleIdList": ["10.1016/j.clinre.2016.07.005", "27597641"]}, {"Citation": "Rafiq N., Younossi Z. M. Nonalcoholic fatty liver disease: a practical approach to evaluation and management. Clinics in Liver Disease. 2009;13(2):249\u2013266. doi: 10.1016/j.cld.2009.02.009.", "ArticleIdList": ["10.1016/j.cld.2009.02.009", "19442917"]}, {"Citation": "Ong J. P., Pitts A., Younossi Z. M. Increased overall mortality and liver-related mortality in non-alcoholic fatty liver disease. Journal of Hepatology. 2008;49(4):608\u2013612. doi: 10.1016/j.jhep.2008.06.018.", "ArticleIdList": ["10.1016/j.jhep.2008.06.018", "18682312"]}, {"Citation": "Ong J. P., Younossi Z. M. Epidemiology and natural history of NAFLD and NASH. Clinics in Liver Disease. 2007;11(1):1\u201316. doi: 10.1016/j.cld.2007.02.009.", "ArticleIdList": ["10.1016/j.cld.2007.02.009", "17544968"]}, {"Citation": "Tolman K. G., Fonseca V., Tan M. H., Dalpiaz A. Narrative review: Hepatobiliary disease in type 2 diabetes mellitus. Annals of Internal Medicine. 2004;141(12):946\u2013956. doi: 10.7326/0003-4819-141-12-200412210-00011.", "ArticleIdList": ["10.7326/0003-4819-141-12-200412210-00011", "15611492"]}, {"Citation": "Shen J., Zhang J., Wen J., Ming Q., Xu Y. Correlation of serum alanine aminotransferase and aspartate aminotransferase with coronary heart disease. International Journal of Clinical and Experimental Medicine. 2015;8(3):4399\u20134404.", "ArticleIdList": ["PMC4443194", "26064360"]}, {"Citation": "Schindhelm R. K., Dekker J. M., Nijpels G., et al. Alanine aminotransferase predicts coronary heart disease events: a 10-year follow-up of the hoorn study. Atherosclerosis. 2007;191(2):391\u2013396. doi: 10.1016/j.atherosclerosis.2006.04.006.", "ArticleIdList": ["10.1016/j.atherosclerosis.2006.04.006", "16682043"]}, {"Citation": "Moghaddasifar I., Lankarani K. B., Moosazadeh M., et al. Prevalence of non-alcoholic fatty liver disease and its related factors in Iran. International Journal of Organ Transplantation Medicine. 2016;7(3):149\u2013160.", "ArticleIdList": ["PMC5054138", "27721961"]}, {"Citation": "Molendi-Coste O., Legry V., Leclercq I. A. Dietary lipids and NAFLD: suggestions for improved nutrition. Acta Gastro-Enterologica Belgica. 2010;73(4):431\u2013436.", "ArticleIdList": ["21299150"]}, {"Citation": "Buettner R., Parhofer K. G., Woenckhaus M., et al. Defining high-fat-diet rat models: metabolic and molecular effects of different fat types. Molecular Endocrinology. 2006;36(3):485\u2013501. doi: 10.1677/jme.1.01909.", "ArticleIdList": ["10.1677/jme.1.01909", "16720718"]}, {"Citation": "Zelber-Sagi S., Ratziu V., Oren R. Nutrition and physical activity in NAFLD: an overview of the epidemiological evidence. World Journal of Gastroenterology. 2011;17(29):3377\u20133389. doi: 10.3748/wjg.v17.i29.3377.", "ArticleIdList": ["10.3748/wjg.v17.i29.3377", "PMC3160564", "21876630"]}, {"Citation": "Ryan M. C., Itsiopoulos C., Thodis T., et al. The Mediterranean diet improves hepatic steatosis and insulin sensitivity in individuals with non-alcoholic fatty liver disease. Journal of Hepatology. 2013;59(1):138\u2013143. doi: 10.1016/j.jhep.2013.02.012.", "ArticleIdList": ["10.1016/j.jhep.2013.02.012", "23485520"]}, {"Citation": "Assy N., Nassar F., Nasser G., Grosovski M. Olive oil consumption and non-alcoholic fatty liver disease. World Journal of Gastroenterology. 2009;15(15):1809\u20131815. doi: 10.3748/wjg.15.1809.", "ArticleIdList": ["10.3748/wjg.15.1809", "PMC2670406", "19370776"]}, {"Citation": "Zelber-Sagi S., Salomone F., Mlynarsky L. The Mediterranean dietary pattern as the diet of choice for non-alcoholic fatty liver disease: evidence and plausible mechanisms. Liver International. 2017;37(7):936\u2013949. doi: 10.1111/liv.13435.", "ArticleIdList": ["10.1111/liv.13435", "28371239"]}, {"Citation": "Hussein O., Grosovski M., Lasri E., Svalb S., Ravid U., Assy N. Monounsaturated fat decreases hepatic lipid content in non-alcoholic fatty liver disease in rats. World Journal of Gastroenterology. 2007;13(3):361\u2013368. doi: 10.3748/wjg.v13.i3.361.", "ArticleIdList": ["10.3748/wjg.v13.i3.361", "PMC4065889", "17230603"]}, {"Citation": "Hern\u00e1ndez R., Mart\u00ednez-Lara E., Ca\u00f1uelo A., et al. Steatosis recovery after treatment with a balanced sunflower of olive oil-based diet: Involvement of perisinusoidal stellate cells. World Journal of Gastroenterology. 2005;11(47):7480\u20137485. doi: 10.3748/wjg.v11.i47.7480.", "ArticleIdList": ["10.3748/wjg.v11.i47.7480", "PMC4725159", "16437720"]}, {"Citation": "Szende B., Tim\u00e1r F., Hargitai B. Olive oil decreases liver damage in rats caused by carbon tetrachloride (CCl4) Experimental and Toxicologic Pathology. 1994;46(4-5):355\u2013359. doi: 10.1016/S0940-2993(11)80116-8.", "ArticleIdList": ["10.1016/S0940-2993(11)80116-8", "7894247"]}, {"Citation": "Fraser A., Abel R., Lawlor D. A., Fraser D., Elhayany A. A modified Mediterranean diet is associated with the greatest reduction in alanine aminotransferase levels in obese type 2 diabetes patients: Results of a quasi-randomised controlled trial. Diabetologia. 2008;51(9):1616\u20131622. doi: 10.1007/s00125-008-1049-1.", "ArticleIdList": ["10.1007/s00125-008-1049-1", "18597068"]}, {"Citation": "Bozzetto L., Prinster A., Annuzzi G., et al. Liver fat is reduced by an isoenergetic MUFA diet in a controlled randomized study in type 2 diabetic patients. Diabetes Care. 2012;35(7):1429\u20131435. doi: 10.2337/dc12-0033.", "ArticleIdList": ["10.2337/dc12-0033", "PMC3379578", "22723581"]}, {"Citation": "Nigam P., Bhatt S., Misra A., et al. Effect of a 6-month intervention with cooking oils containing a high concentration of monounsaturated fatty acids (olive and canola oils) compared with control oil in male asian indians with nonalcoholic fatty liver disease. Diabetes Technology & Therapeutics. 2014;16(4):255\u2013261. doi: 10.1089/dia.2013.0178.", "ArticleIdList": ["10.1089/dia.2013.0178", "24625239"]}, {"Citation": "Lam B. P., Younossi Z. M. Treatment regimens for non-alcoholic fatty liver disease. Annals of Hepatology. 2009;8(supplement 1):S51\u2013S59.", "ArticleIdList": ["19381125"]}, {"Citation": "Harrison S. A., Fecht W., Brunt E. M., Neuschwander-Tetri B. A. Orlistat for overweight subjects with nonalcoholic steatohepatitis: a randomized, prospective trial. Hepatology. 2009;49(1):80\u201386. doi: 10.1002/hep.22575.", "ArticleIdList": ["10.1002/hep.22575", "19053049"]}, {"Citation": "Promrat K., Kleiner D. E., Niemeier H. M., et al. Randomized controlled trial testing the effects of weight loss on nonalcoholic steatohepatitis. Hepatology. 2010;51(1):121\u2013129. doi: 10.1002/hep.23276.", "ArticleIdList": ["10.1002/hep.23276", "PMC2799538", "19827166"]}, {"Citation": "Tiikkainen M., Bergholm R., Vehkavaara S., et al. Effects of identical weight loss on body composition and features of insulin resistance in obese women with high and low liver fat content. Diabetes. 2003;52(3):701\u2013707. doi: 10.2337/diabetes.52.3.701.", "ArticleIdList": ["10.2337/diabetes.52.3.701", "12606511"]}, {"Citation": "Donnelly K. L., Smith C. I., Schwarzenberg S. J., Jessurun J., Boldt M. D., Parks E. J. Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease. The Journal of Clinical Investigation. 2005;115(5):1343\u20131351. doi: 10.1172/JCI200523621.", "ArticleIdList": ["10.1172/JCI200523621", "PMC1087172", "15864352"]}, {"Citation": "DeLany J. P., Windhauser M. M., Champagne C. M., Bray G. A. Differential oxidation of individual dietary fatty acids in humans. American Journal of Clinical Nutrition. 2000;72(4):905\u2013911. doi: 10.1093/ajcn/72.4.905.", "ArticleIdList": ["10.1093/ajcn/72.4.905", "11010930"]}, {"Citation": "Rivellese A. A., Giacco R., Annuzzi G., et al. Effects of monounsaturated vs. saturated fat on postprandial lipemia and adipose tissue lipases in type 2 diabetes. Clinical Nutrition. 2008;27(1):133\u2013141. doi: 10.1016/j.clnu.2007.07.005.", "ArticleIdList": ["10.1016/j.clnu.2007.07.005", "17765364"]}, {"Citation": "Dongiovanni P., Valenti L. A nutrigenomic approach to non-alcoholic fatty liver disease. International Journal of Molecular Sciences. 2017;18(7, article 1534) doi: 10.3390/ijms18071534.", "ArticleIdList": ["10.3390/ijms18071534", "PMC5536022", "28714900"]}, {"Citation": "Guo J., Ren W., Li A., et al. Fat mass and obesity-associated gene enhances oxidative stress and lipogenesis in nonalcoholic fatty liver disease. Digestive Diseases and Sciences. 2013;58(4):1004\u20131009. doi: 10.1007/s10620-012-2516-6.", "ArticleIdList": ["10.1007/s10620-012-2516-6", "23329013"]}, {"Citation": "Doaei S., Kalantari N., Mohammadi N. K., Tabesh G. A., Gholamalizadeh M. Macronutrients and the FTO gene expression in hypothalamus; a systematic review of experimental studies. Indian Heart Journal. 2017;69(2):277\u2013281. doi: 10.1016/j.ihj.2017.01.014.", "ArticleIdList": ["10.1016/j.ihj.2017.01.014", "PMC5414942", "28460778"]}, {"Citation": "Kalantari N., Doaei S., Keshavarz-Mohammadi N., Gholamalizadeh M., Pazan N. Review of studies on the fat mass and obesity-associated (FTO) gene interactions with environmental factors affecting on obesity and its impact on lifestyle interventions. ARYA Atherosclerosis. 2016;12(6):281\u2013290.", "ArticleIdList": ["PMC5455327", "28607568"]}, {"Citation": "Ma X., Holalkere N. S., Kambadakone R. A., Mino-Kenudson M., Hahn P. F., Sahani D. V. Imaging-based quantification of hepatic fat: methods and clinical applications. RadioGraphics. 2009;29(5):1253\u20131277. doi: 10.1148/rg.295085186.", "ArticleIdList": ["10.1148/rg.295085186", "19755595"]}]}], "History": [{"Year": "2017", "Month": "12", "Day": "25"}, {"Year": "2018", "Month": "2", "Day": "15"}, {"Year": "2018", "Month": "2", "Day": "25"}, {"Year": "2018", "Month": "6", "Day": "1", "Hour": "6", "Minute": "0"}, {"Year": "2018", "Month": "6", "Day": "1", "Hour": "6", "Minute": "0"}, {"Year": "2019", "Month": "4", "Day": "4", "Hour": "6", "Minute": "0"}, {"Year": "2018", "Month": "4", "Day": "17"}], "PublicationStatus": "epublish", "ArticleIdList": ["29850450", "PMC5932499", "10.1155/2018/1053710"]}}]}